Bipartisan legislation co-sponsored by Reps. Diana DeGette, D-CO, and Tom Reed, R-NY, seeks to drive down insulin costs by eliminating rebates for products whose list prices have been returned to 2006 levels.
The Insulin Price Reduction Act would offer manufacturers incentives for dramatically lowering insulin prices by prohibiting rebates for insulins...






